Professional Documents
Culture Documents
Moderator
Dr. Arun Kumar K.V.
Contents.
Introduction
Historical
background
Definition
Desirable
characteristic
Anatomic
consideration
Physiologic
considerations
Mode and site of
action of local
anesthetic
Kinetics of L.A.
Pharmacology of
LA.
Potentiation of
action of local
anestheticsvasoconstrictors
Recent advances
and future trends in
pain control
Chronic paincurrent modes of
treatment
Conclusion
References
Introduction
Historical background
Historical background
Definition
Local anesthesia
Mechanical trauma
Low temperature
Anoxia
Chemical irritants
Neurolytic agents such as a
alcohol and phenols
Chemical agents such as local
anesthetics.
Desirable characteristics
of local anesthesia .
Non irritating
Desirable characteristics
of local anesthesia .
Sterile
Anatomic
Neuron
considerations
Sensory
Motor
Histochemistry
Physiologic
considerations
STEP- 1
Intracellular
(MEQ/L)
Extracellular
(MEQ/L)
Ratio
Potassium (K+)
110-170
3-5
27:1
Sodium (Na+)
5-10
140
1:14
Chloride (Cl-)
5-10
110
1:11
STEP- 2
STEP - 3
Membrane
channels
IMPULSE PROPAGATION
IMPULSE SPREAD
Unmyelinated nerves
Myelinated nerves
Mode of action of
local anesthetic
local anesthetic agents interfere with excitation process in
Mechanism of action
RNHOH + HCl RNHCL + H2O
Weak strong
acid
water
Base
acid
salt
RNH+ displaces calcium ions for the sodium channel receptor site.
which causes
Binding of the local anesthetic molecules to this receptor site
which produce
Blockade of sodium channel
and
Decrease in sodium conduction
which leads to
Depression of the rate of electrical depolarization
and
Failure to achieve the threshold potential level
Effect of pH
Log Base
Acid
pH pKa
Theories of mechanism
of action of L.A
Diffusion local
anesthetics
Recurrence of immediate
propound anesthesia
Difficultly in re-achieving
profound anesthesia
Tachyphylaxis
Pharmacology of local
anesthetics
Classification
Based on chemical structure
AMIDE
ESTER
benzoic acid
PABA
QUINOLINE
Synthetic
Others
Injectable
Short
Medium
Long
Intermediate
Long
Pharmacokinetics of
local anesthetics
Uptake
Oral route
Topical route
Injection
Metabolism
Esters
Amides
Excretion
Individual local
anesthetic agents
Drug
potency toxicity
pKa
Procaine
9.1
Propoxyc
aine
7-8
7-8
pH
Conc onset
used
life
hr
0.4% 2-3
min
Drug
potency toxicity
pKa
pH
Conc onset
used
life
Lidocaine
7.9
6.5
5-5.5
2%
2-3
min
1.6
hr
Mepivaca
ine
1.5-2
7.6
4.5
3-3.5
3%
2%
1.5-2
min
1.9
hr
Prilocaine
7.9
4.5
3-4
4%
2-4
min
1.6
hr
Drug
pKa
pH
Conc
used
7.8
4.45.2
4%
2-3
min
1.25
hrs
Bupivacai
4
<4
ne
(lidoc.) (lidoc.)
8.1
2.7
hr
Etidocain
4
2
e
(lidoc.) (lidoc.)
7.7
2.6
hr
Articaine
potency toxicity
onset life
Potentiation of action
ofVasoconstrictors
local anesthesia
pH alterations
Alkalinization
Carbonation
Potassium potentiation
Dextran prolongation
Oil solutions
Hyaluronidase
Miscellaneous
Vasoconstrictors
Decrease bleeding
Sympathomimetic drugs
Chemical structure
HO
C-C
HO
Classification
Catecholamines
Non catecholamines
Catecholamines
Non catecholamines
Epinephrine
Amphetamine
Nor-
Methamphetamine
epinephrine
Hydroxy-amphetamine
Ephedrine
Mephetermine
Dopamine
Levonordefrin
Isoproterenol
Adrenergic receptors
Ahlquist in 1948
Two types
Alpha () vasoconstriction
Epinephrine
Vasculature
Vasoconstriction
& kidneys
Vasodilation
doses
Respiratory - Bronchodilator
Metabolism
Increase
oxygen consumption
Glycogenolysis-
blood sugar
Termination of Epinephrine
Reuptake
Cardiac dysrhythmia
Ventricular fibrillation
Bronchospasm
Cardiac arrest
Hemostasis
Produce mydriasis
Vasoconstrictor
Norepinephrine
Dilutions of vasoconstrictors:
Dilution
Mg/ml
Therapeutic use
1:1,000
1.0
Emergency
medicine
(Im/Sc anaphylaxis)
1:2,500
0.4
Phenylephrine
1:10,000
0.1
1:20,000
0.05
Levonordefrin
1:30,000
0.033
Norepinephrine
1:50,000
0.02
Local anesthesia
1:80,000
0.0125
Local anesthesia
1:100,000
0.01
Local anesthesia
1:2000,000
0.005
Local anesthesia
Centbucridine
quinalone derivative
Ropivacaine
prepared as a isomer
decreased cardio-toxicity
EMLA
pH alterations
Alkalinization - RN
Carbonation
Hyaluronidase
saxitoxin -dinoflagelates.
Felypressin
Indications
Acute pain
Restorative dentistry
Contraindications
Cardiac pacemakers
Neurological disorders
Status post cerebrovascular accident
History of transient ischemic attacks
History of epilepsy
Pregnancy
Immaturity (in ability to understand) the concept
of patient control of pain)
Very young pediatric patient
Older patients with senile dementia
Language communication difficulties
Advantages
Disadvantages
Drug therapy
Weak opioids
Strong opioids
Blocks of ANS
Cryoanalgesia
Chemical hypophysectomy
Percutaneous cordotomy
Acupuncture
Psychotherapy
Hypnosis
References
Internet references:
Google.com
Alta vista.com
Alltheweb.com
Medvizion.net
Emedicine.net.
Thank you